ARCHIVES

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Kington Named Acting NIH Director.

November 14, 2008

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982

Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected

November 14, 1986